Progyny, Inc.
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
PGNY$36.43+1.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements Comprehensive Income
(in thousands)
| Year EndedDecember 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net income | $58,520 | $54,336 | $62,037 |
| Other comprehensive income (loss), net of tax: | |||
| Unrealized gain on marketable securities before reclassifications | 133 | 4,500 | 6,143 |
| Reclassification of gains on the sale of marketable securities into net income | — | (7,311) | (3,810) |
| Net change on unrealized gains on marketable securities | 133 | (2,811) | 2,333 |
| Foreign currency translation gain (loss) | 326 | 31 | (15) |
| Total other comprehensive income (loss), net of tax | 459 | (2,780) | 2,318 |
| Total comprehensive income | $58,979 | $51,556 | $64,355 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.